Chalmers, J. D., Burgel, P., Daley, C. L., De Soyza, A., Haworth, C. S., Mauger, D., . . . Metersky, M. L. (2025). Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. The New England journal of medicine, 392(16), 1569-1581. https://doi.org/10.1056/NEJMoa2411664
Citácia podle Chicago (17th ed.)Chalmers, James D., et al. "Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis." The New England Journal of Medicine 392, no. 16 (2025): 1569-1581. https://doi.org/10.1056/NEJMoa2411664.
Citácia podľa MLA (8th ed.)Chalmers, James D., et al. "Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis." The New England Journal of Medicine, vol. 392, no. 16, 2025, pp. 1569-1581, https://doi.org/10.1056/NEJMoa2411664.
Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..